METRONIDAZOLO SALF 500mg/100ml solution for infusion

Treatment of serious infections caused by anaerobic

bacteria, in particular Bacteroides fragilis,

other species of Bacteroides and other anaerobes

on which metronidazole has a bactericidal

effect, such as Fusobacteria, Eubacteria,

Clostridia and gram-positive anaerobic cocci.

Metronidazole has been used with positive

results in septicemia, bacteremia, brain abscess,

necrotizing pneumonia, osteomyelitis,

puerperal fever, pelvic abscess, peritonitis and

post-operative wounds, where one or more of

the above-mentioned anaerobic bacteria were

isolated.

Prevention of post-operative infections caused

by anaerobic bacteria, especially Bacteroides

and anaerobic gram-positive cocci.

Metronidazole, primarily employed for many

years for the treatment of urogenital trichomoniasis,

subsequently it turned out to be an active

drug against a wide variety of anaerobic bacteria

of clinical interest. Actually, Metronidazole has

a bactericidal effect on obligate anaerobes, for

which the minimum “in vitro” inhibitory concentration

and the minimum bactericidal concentration

of the drug are almost identical. Aerobic

bacteria and facultative anaerobes are insensitive,

instead.

PACKAGING:

- Box containing 20 x 100 ml PVCfree bags

AIC 041491010 (Italian MA).

- Box containing 25 x 100 ml PP bottles